Hologic (Hologic) EBIT per Share : $3.00 (TTM As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is Hologic EBIT per Share?

Hologic's EBIT per Share for the three months ended in Dec. 2023 was $0.91. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.00.

During the past 12 months, the average EBIT per Share Growth Rate of Hologic was -40.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hologic's EBIT per Share or its related term are showing as below:

HOLX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -40.5 Med: 20.75 Max: 203.1
Current: -10.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Hologic was 203.10% per year. The lowest was -40.50% per year. And the median was 20.75% per year.

HOLX's 3-Year EBIT Growth Rate is ranked worse than
71.37% of 723 companies
in the Medical Devices & Instruments industry
Industry Median: 6.7 vs HOLX: -10.40

Hologic's EBIT for the three months ended in Dec. 2023 was $217 Mil.

Hologic EBIT per Share Historical Data

The historical data trend for Hologic's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic EBIT per Share Chart

Hologic Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT per Share

Get a 7-Day Free Trial

-0.43

4.23

9.45

6.63

3.16

Hologic Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															1.07	1.23	0.16	0.70	0.91

Hologic EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hologic's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

	EBIT per Share		(A: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	787.2	/	248.831
=	3.16

Hologic's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	217.3	/	240.214
=	0.90

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.00

Hologic (NAS:HOLX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Hologic EBIT per Share Related Terms

Thank you for viewing the detailed overview of Hologic's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hologic (Hologic) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (NAS:HOLX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

HOLX:Mexico HO1:Germany HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Executives

Charles J Dockendorff	director	COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Scott T Garrett	director	35 CROSBY DRIVE, BEDFORD MA 01730
Stephen P Macmillan	director, officer: President and CEO	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Essex D Mitchell	officer: Div. President, GYN Surgical	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Nanaz Mohtashami	director	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Jennifer M Schneiders	officer: President, Diag. Solutions	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Benjamin Jordan Cohn	officer: Principal Accounting Officer	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Stacey D. Stewart	director	5920 WALHONDING ROAD, BETHESDA MD 20816
Elisabeth A Hellmann	officer: SVP, Human Resources	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Kevin R Thornal	officer: Div. President, Diagnostics	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
John M. Griffin	officer: General Counsel	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Karleen Marie Oberton	officer: Corp. VP, Finance & Acconting	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Erik S Anderson	officer: Div. Pres., Breast & Skeletal	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Jan Verstreken	officer: Group President, International	250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Allison P Bebo	officer: SVP, Human Resources	250 CAMPUS DRIVE, MARLBOROUGH MA 01752